CP and cancer: Cancer patients were vaccinated (n = 376; 79.1%), mostly by mRNA BNT162b2 (n = 218; 57%) or AZD1222 (n = 39; 10.4%), less frequently by the mRNA-1273 vaccine (n = 16; 4.3%) and for more than one fourth of CP the name of the vaccine was unknown.